These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 38963636)
1. CAR-T cell therapy in AML: recent progress and future perspectives. Saito S; Nakazawa Y Int J Hematol; 2024 Oct; 120(4):455-466. PubMed ID: 38963636 [TBL] [Abstract][Full Text] [Related]
2. [Current state and future prospects of CAR T-cell therapy for myeloid malignancies]. Saito S Rinsho Ketsueki; 2024; 65(7):634-643. PubMed ID: 39098014 [TBL] [Abstract][Full Text] [Related]
3. Recent progress in chimeric antigen receptor therapy for acute myeloid leukemia. Wang X; Zhang Y; Xue S Ann Hematol; 2024 Jun; 103(6):1843-1857. PubMed ID: 38381173 [TBL] [Abstract][Full Text] [Related]
4. Development of A Chimeric Antigen Receptor Targeting C-Type Lectin-Like Molecule-1 for Human Acute Myeloid Leukemia. Laborda E; Mazagova M; Shao S; Wang X; Quirino H; Woods AK; Hampton EN; Rodgers DT; Kim CH; Schultz PG; Young TS Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29077054 [TBL] [Abstract][Full Text] [Related]
5. Chimeric Antigen Receptor T Cells Targeting NKG2D-Ligands Show Robust Efficacy Against Acute Myeloid Leukemia and T-Cell Acute Lymphoblastic Leukemia. Driouk L; Gicobi JK; Kamihara Y; Rutherford K; Dranoff G; Ritz J; Baumeister SHC Front Immunol; 2020; 11():580328. PubMed ID: 33384686 [TBL] [Abstract][Full Text] [Related]
6. Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients. Marofi F; Rahman HS; Al-Obaidi ZMJ; Jalil AT; Abdelbasset WK; Suksatan W; Dorofeev AE; Shomali N; Chartrand MS; Pathak Y; Hassanzadeh A; Baradaran B; Ahmadi M; Saeedi H; Tahmasebi S; Jarahian M Stem Cell Res Ther; 2021 Aug; 12(1):465. PubMed ID: 34412685 [TBL] [Abstract][Full Text] [Related]
7. CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia. Wang J; Chen S; Xiao W; Li W; Wang L; Yang S; Wang W; Xu L; Liao S; Liu W; Wang Y; Liu N; Zhang J; Xia X; Kang T; Chen G; Cai X; Yang H; Zhang X; Lu Y; Zhou P J Hematol Oncol; 2018 Jan; 11(1):7. PubMed ID: 29316944 [TBL] [Abstract][Full Text] [Related]
8. Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia. Jetani H; Navarro-Bailón A; Maucher M; Frenz S; Verbruggen C; Yeguas A; Vidriales MB; González M; Rial Saborido J; Kraus S; Mestermann K; Thomas S; Bonig H; Luu M; Monjezi R; Mougiakakos D; Sauer M; Einsele H; Hudecek M Blood; 2021 Nov; 138(19):1830-1842. PubMed ID: 34289026 [TBL] [Abstract][Full Text] [Related]
9. Valproic acid increases CAR T cell cytotoxicity against acute myeloid leukemia. Wen J; Chen Y; Yang J; Dai C; Yu S; Zhong W; Liu L; He C; Zhang W; Yang T; Liu L; Hu J J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37524506 [TBL] [Abstract][Full Text] [Related]
10. Allogeneic FLT3 CAR T Cells with an Off-Switch Exhibit Potent Activity against AML and Can Be Depleted to Expedite Bone Marrow Recovery. Sommer C; Cheng HY; Nguyen D; Dettling D; Yeung YA; Sutton J; Hamze M; Valton J; Smith J; Djuretic I; Chaparro-Riggers J; Sasu BJ Mol Ther; 2020 Oct; 28(10):2237-2251. PubMed ID: 32592688 [TBL] [Abstract][Full Text] [Related]
11. Tandem bispecific CD123/CLL-1 CAR-T cells exhibit specific cytolytic effector functions against human acute myeloid leukaemia. Wang XY; Bian MR; Lin GQ; Yu L; Zhang YM; Wu DP Eur J Haematol; 2024 Jan; 112(1):83-93. PubMed ID: 37712633 [TBL] [Abstract][Full Text] [Related]
12. INSPIRED Symposium Part 5: Expanding the Use of CAR T Cells in Children and Young Adults. Talleur AC; Fabrizio VA; Aplenc R; Grupp SA; Mackall C; Majzner R; Nguyen R; Rouce R; Moskop A; McNerney KO Transplant Cell Ther; 2024 Jun; 30(6):565-579. PubMed ID: 38588880 [TBL] [Abstract][Full Text] [Related]
14. Naturally selected CD7 CAR-T therapy without genetic editing demonstrates significant antitumour efficacy against relapsed and refractory acute myeloid leukaemia (R/R-AML). Lu Y; Liu Y; Wen S; Kuang N; Zhang X; Li J; Wang F J Transl Med; 2022 Dec; 20(1):600. PubMed ID: 36517851 [TBL] [Abstract][Full Text] [Related]
15. Combinatorial antigen targeting strategies for acute leukemia: application in myeloid malignancy. Atilla PA; McKenna MK; Watanabe N; Mamonkin M; Brenner MK; Atilla E Cytotherapy; 2022 Mar; 24(3):282-290. PubMed ID: 34955406 [TBL] [Abstract][Full Text] [Related]
16. How close are we to CAR T-cell therapy for AML? Gill SI Best Pract Res Clin Haematol; 2019 Dec; 32(4):101104. PubMed ID: 31779970 [TBL] [Abstract][Full Text] [Related]